Delivery Order SPE2DB20D1109-SPE2DB25FP44D
- Not listed
- The Defense Logistics Agency awarded a $3,214.86 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes in 0.5 ml quantities, with final delivery due by August 12, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $28,778.14 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 ml syringes on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order supports pharmaceutical supply needs for military and federal healthcare systems, with performance based at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a $10,741.92 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes valued at $8,591.59, with an ultimate completion date of October 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The award was competitively procured...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,132.07 under firm fixed price terms. The delivery order is not set-aside and represents a competitively awarded procurement. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $1,446.14. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, consistent with AmerisourceBergen's typical federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.23 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of June 23, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $7,143.38 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Phytonadione 10 mg/ml ampules. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This is a $1,903.20 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the drug Phytonadione 1 mg/0.5 ml syringe with a completion date of July 16, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP44DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2.87K with a completion date of July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical procurement needs across the Department of Defense healthcare system. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/23/25 |